1. Fujimura KE, Slusher NA, Cabana MD, Lynch SV. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 2010;8(4):435-54. [DOI:10.1586/eri.10.14]

2. Tanagho PA, Shohdy KS. GPR 120: The Potential Target for Obesity Treatment. Endocr Metab Immune Disord Drug Targets 2016;16:8-11. [DOI:10.2174/1871530316666151123115611]

3. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Beneficial modulation of the gut microbiota. FEBS Lett 2014;588:4120-30. [DOI:10.1016/j.febslet.2014.03.035]

4. Kho ZY, Lal SK. The human gut microbiome-a potential controller of wellness and disease. Front Microbiol 2018:1835. [DOI:10.3389/fmicb.2018.01835]

5. Hooks KB, O'Malley MA. Dysbiosis and its discontents. MBio 2017;8:e01492-17. [DOI:10.1128/mBio.01492-17]

6. Di Lorenzo F, De Castro C, Silipo A, Molinaro A. Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions. FEMS Microbiol Rev 2019;43:257-72. [DOI:10.1093/femsre/fuz002]

7. Behrouzi A, Mazaheri H, Falsafi S, Tavassol ZH, Moshiri A, Siadat SD. Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. J Diab Metab Disord 2020;19:597-604. [DOI:10.1007/s40200-020-00511-6]

8. Sharifi L, Aghamohammadi A, Mohsenzadegan M, Rezaei N, Towfighi Zavareh F, Moshiri M, et al. Immunomodulation of TLR2 and TLR4 by G2013 (alfa-L-Guluronic acid) in CVID Patients. Int J Pediatr 2017;5:5327-37.

9. Chen C-Y, Kao C-L, Liu C-M. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway. Int J Mol Sci 2018;19:2729. [DOI:10.3390/ijms19092729]

10. Llewellyn A, Foey A. Probiotic modulation of innate cell pathogen sensing and signaling events. Nutrients 2017;9:1156. [DOI:10.3390/nu9101156]

11. Molina-Tijeras JA, Gálvez J, Rodríguez-Cabezas ME. The immunomodulatory properties of extracellular vesicles derived from probiotics: a novel approach for the management of gastrointestinal diseases. Nutrients 2019;11:1038. [DOI:10.3390/nu11051038]

12. Wegh CA, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and their potential applications in early life nutrition and beyond. Int J Mol Sci 2019;20:4673. [DOI:10.3390/ijms20194673]

13. Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 2021;18:649-67. [DOI:10.1038/s41575-021-00440-6]

14. Teame T, Wang A, Xie M, Zhang Z, Yang Y, Ding Q, et al. Paraprobiotics and postbiotics of probiotic lactobacilli, their positive effects on the host and action mechanisms: a review. Front Nutr 2020;7:570344. [DOI:10.3389/fnut.2020.570344]

15. Chang C-J, Lin T-L, Tsai Y-L, Wu T-R, Lai W-F, Lu C-C, et al. Next generation probiotics in disease amelioration. J Food Drug Anal 2019;27:615-22. [DOI:10.1016/j.jfda.2018.12.011]

16. Thompson AJ, Spears RJ, Zhu Y, Suits MD, Williams SJ, Gilbert HJ, et al. Bacteroides thetaiotaomicron generates diverse α-mannosidase activities through subtle evolution of a distal substrate-binding motif. Acta Crystallogr D Struct Biol 2018;74:394-404. [DOI:10.1107/S2059798318002942]

17. Carvalho AL, Fonseca S, Miquel-Clopés A, Cross K, Kok K-S, Wegmann U, et al. Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract. J Extracell Vesicles 2019;8:1632100. [DOI:10.1080/20013078.2019.1632100]

18. Huang-Doran I, Zhang C-Y, Vidal-Puig A. Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab 2017;28:3-18. [DOI:10.1016/j.tem.2016.10.003]

19. Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. BioMed Res Int 2018;2018. [DOI:10.1155/2018/8545347]

20. Fujita Y, Kadota T, Araya J, Ochiya T, Kuwano K. Extracellular vesicles: new players in lung immunity. Am J Respir Cell Mol Biol 2018;58:560-65. [DOI:10.1165/rcmb.2017-0293TR]

21. Ashrafian F, Behrouzi A, Badi SA, Davari M, Jamnani FR, Fateh A, et al. Comparative study of effect of Akkermansia muciniphila and its extracellular vesicles on toll-like receptors and tight junction. Gastroenterol Hepatol Bed Bench 2019;12:163.

22. Valguarnera E, Scott NE, Azimzadeh P, Feldman MF. Surface exposure and packing of lipoproteins into outer membrane vesicles are coupled processes in Bacteroides. MSphere 2018;3:e00559-18. [DOI:10.1128/mSphere.00559-18]

23. Badi SA, Moshiri A, Marvasti FE, Mojtahedzadeh M, Kazemi V, Siadat SD. Extraction and evaluation of outer membrane vesicles from two important gut microbiota members, Bacteroides fragilis and Bacteroides thetaiotaomicron. Cell J (Yakhteh) 2020;22:344.

24. Wei S-H, Chen Y-P, Chen M-J. Selecting probiotics with the abilities of enhancing GLP-1 to mitigate the progression of type 1 diabetes in vitro and in vivo. Journal of Functional Foods 2015;18:473-86. [DOI:10.1016/j.jff.2015.08.016]

25. DW sJaR, eds. Molecular cloninig:a laboratory manual. 3 ed. New York: Cold Spring Harbor Laboratory Press; 2001.

26. Ashrafian F, Shahriary A, Behrouzi A, Moradi HR, Keshavarz Azizi Raftar S, Lari A, et al. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front Microbiol 2019;10:2155. [DOI:10.3389/fmicb.2019.02155]

27. Bonomi L, Brown M, Ungerleider N, Muse M, Matzuk MM, Schneyer A. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity. Am J Physiol Endocrinol Metab 2012;303:E587-96. [DOI:10.1152/ajpendo.00177.2012]

28. Motta EVS, Powell JE, Leonard SP, Moran NA. Prospects for probiotics in social bees. Philos Trans R Soc Lond B Biol Sci 2022;377:20210156. [DOI:10.1098/rstb.2021.0156]

29. Korotkyi O, Huet A, Dvorshchenko K, Kobyliak N, Falalyeyeva T, Ostapchenko L. Probiotic composition and chondroitin sulfate regulate TLR-2/4-mediated NF-κB inflammatory pathway and cartilage metabolism in experimental osteoarthritis. Probiotics Antimicrob Proteins 2021;13:1018-32. [DOI:10.1007/s12602-020-09735-7]

30. Ganguli K, Collado MC, Rautava J, Lu L, Satokari R, von Ossowski I, et al. Lactobacillus rhamnosus GG and its SpaC pilus adhesin modulate inflammatory responsiveness and TLR-related gene expression in the fetal human gut. Pediatr Res 2015;77:528-35. [DOI:10.1038/pr.2015.5]

31. Zhang B, Zhao J, Jiang M, Peng D, Dou X, Song Y, et al. The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment. Front Immunol 2022;13. [DOI:10.3389/fimmu.2022.893617]

32. Wegh CAM, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and their potential applications in early life nutrition and beyond. Int J Mol Sci 2019;20:4673. [DOI:10.3390/ijms20194673]

33. Van Bergenhenegouwen J, Kraneveld AD, Rutten L, Kettelarij N, Garssen J, Vos AP. Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis. PloS One 2014;9:e89121. [DOI:10.1371/journal.pone.0089121]

34. Badi SA, Khatami S, Irani S, Siadat SD. Induction effects of bacteroides fragilis derived outer membrane vesicles on toll like receptor 2, toll like receptor 4 genes expression and cytokines concentration in human intestinal epithelial cells. Cell J (Yakhteh) 2019;21:57.

35. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, et al. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PloS One 2013;8:e59370. [DOI:10.1371/journal.pone.0059370]

36. Malago J, Tooten P, Koninkx JF. Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells. Benef Microbes 2010;1:121-30. [DOI:10.3920/BM2009.0021]

37. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2010;105:2218. [DOI:10.1038/ajg.2010.218]